ArthroCare (Austin, Texas) shares may be trading less on fundamentals and more on the firm's take-out potential, according to Canaccord Genuity (Toronto) analyst William Plovanic. The med-tech analyst penned his thoughts regarding ArthroCare as a take-out target in a 13-page report released Tuesday.